TheNote
ViiV Healthcare to present pha... Note
GooglePlay AppStore
GSK press releases

ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026

VOGUE is the first head-to-head, randomised daily orals study comparing 2-drug regimen Dovato with 3-drug regimen Biktarvy
https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-alongside-insti-powered-long-acting-injectable-innovation-at-aids-2026/ gsk.com
RSS Hunter RSS Hunter • Yesterday